| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | Canada | 2 | |
| #3 | United States | 2 | |
| #4 | Australia | 1 | |
| #5 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms | |
| #5 | Analysing materials | |
| #6 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Sette Alessandro | 11 |
| #2 | Chesnut Robert W | 5 |
| #3 | Southwood Scott | 5 |
| #4 | Sidney John | 4 |
| #5 | Fikes John D | 4 |
| #6 | Livingston Brian D | 3 |
| #7 | Ishioka Glenn | 3 |
| #8 | Newman Mark J | 3 |
| #9 | Baker Denise M | 2 |
| #10 | Celis Esteban | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CA2522812A1 | Hla-a2 tumor associated antigen peptides and compositions | |
| EP1609107A2 | Methods of identifying optimal variants of peptide epitopes | |
| EP1903056A2 | HLA-A1, -A2 -A3, -A24, -B7, and -B44 binding peptides comprising tumor associated antigen epitopes, and compositions thereof | |
| EP1571909A2 | Optimized multi-epitope constructs and uses thereof | |
| US7252829B1 | HLA binding peptides and their uses |